Josamec (Lacosamide)

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neurons, which reduces repetitive firing and stabilizes hyperexcitable neuronal membranes, thereby decreasing the likelihood of seizure propagation.

The dosage of Josamec is individualized by the prescribing clinician based on the patient’s clinical condition, age, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lacosamide in pregnancy and lactation are limited. The prescriber must evaluate the potential benefits against possible risks to the fetus or infant before initiating therapy in pregnant or nursing women.

To request Josamec, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with many traditional antiepileptics, lacosamide has a distinct mechanism that targets slow inactivation of sodium channels, offering an alternative for patients who do not respond adequately to drugs that act on fast inactivation. Its side‑effect profile and drug‑interaction potential also differ, which may influence therapeutic choice.

Josamec should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Josamec is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

Serious adverse events may include cardiac arrhythmias such as atrial fibrillation, severe skin reactions, suicidal thoughts or behaviors, hepatic injury, and rare blood disorders. Patients should promptly report any unusual symptoms to their healthcare provider.

Josamec is contraindicated in individuals with known hypersensitivity to lacosamide or any of its excipients. Caution is also advised for patients with significant cardiac conduction abnormalities, uncontrolled arrhythmias, or severe hepatic impairment.